Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
Chen Zhao(Brigham and Women's Hospital), Koichi Matsuo(Hiroshima University), Toru Nishiwaki(Keio University), Toshio Suda(Chinese Academy of Sciences), Naoko Irie(Social Insurance Saitama Chuo Hospital), Takeshi Miyamoto(Kumamoto Health Science University), Yasunari Takada(The University of Texas MD Anderson Cancer Center), Kouji Shimoda(Keio University Hospital)
Cited by 771
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors
|The Journal of Experimental Medicine|1999|694
Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors.
|Journal of Clinical Investigation|1993|577